Cargando…
Urinary coenzyme Q10 as a diagnostic biomarker and predictor of remission in a patient with ADCK4-associated Glomerulopathy: a case report
BACKGROUND: AarF domain-containing kinase 4 (ADCK4)-associated glomerulopathy is a mitochondrial nephropathy caused by mutations in the ADCK4 gene, which disrupt coenzyme Q10 biosynthesis. CASE PRESENTATION: We report the case of a 25-year-old female patient with ADCK4-associated glomerulopathy pres...
Autores principales: | Zhang, Yan, Liao, Xiaohua, Jiang, Yupeng, Lv, Xin, Yu, Yue, Dai, Qin, Ao, Liyun, Tao, Lijian, Peng, Zhangzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791994/ https://www.ncbi.nlm.nih.gov/pubmed/33413146 http://dx.doi.org/10.1186/s12882-020-02208-7 |
Ejemplares similares
-
One-year outcome of coenzyme Q10 supplementation in ADCK3 ataxia (ARCA2)
por: Schirinzi, Tommaso, et al.
Publicado: (2019) -
Early-onset of ADCK4 glomerulopathy with renal failure: a case report
por: Lolin, Ksenija, et al.
Publicado: (2017) -
Coenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review
por: Feng, Chunyue, et al.
Publicado: (2017) -
Early-onset COQ8B (ADCK4) glomerulopathy in a child with isolated proteinuria: a case report and literature review
por: Zhai, Shu-bo, et al.
Publicado: (2020) -
Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury
por: Li, Jiajia, et al.
Publicado: (2022)